University of Southern California

Research

Ming Hsieh Institute for Research on Engineering-Medicine for Cancer

Program Overview

The Hsieh Institute aims to make USC a national and international leader in translational cancer research that bridges basic science, engineered devices, synthesized molecules and materials, and medicine. Established in 2010 through a generous gift from Ming Hsieh (a USC graduate of the Viterbi School of Engineering and founder of Cogent Systems), the centerpiece of the Hsieh Institute will be integrated engineering, scientific and medical research that speeds discovery and creates the pathways by which research rapidly improves the lives of patients with cancer. By embarking on this new interdisciplinary direction, we aim to develop new therapeutic approaches to cancer patients that minimize the adverse effects typically associated with conventional chemotherapeutic agents.

The Ming Hsieh Institute seeks proposals that will initiate new nanomedicine research projects that show exceptional promise for translation into clinical trials for treatment of cancer. Proposals should demonstrate that a modest seed investment will have significant impact, either through initiating a novel research concept, or accelerating research into clinical trials.

Proposal Submission

You will need to log in using your USC NetID and password: Begin Online Application.

Important:  You may experience problems with the online application if using the browser Internet Explorer.  If you experience problems, it is advisable to access the application system through a different browser, such as Mozilla Firefox or Google Chrome.

For questions regarding the proposal submission process, please contact Silvia da Costa in the Office of Research (sdacosta@usc.edu or 213-740-6709).

Proposal Deadline: February 21, 2014.

Download the 2014 Program Guidelines.

View Featured Research of previously awarded proposals.